Recent developments in nanoparticle-mediated cancer immunotherapy promote treatment with less toxicity. Cancer immunotherapy utilizes a patient’s immune system to target and destroy cancer. Many types ...

Research has shown that some nucleic acids, such as messenger RNA (mRNA), DNA and related molecules, can be effective disease treatments in laboratory settings, raising expectations that improved ...

(Nanowerk Spotlight) Advances in nucleic acids research and therapeutic nanotechnology have allowed for the development of rationally designed therapeutic nucleic acids (TNAs) that have played a ...

Harnessing surface engineering strategies to functionalize nucleic acid-lipid nanoparticles (LNPs) for improved performance has been a hot research topic since the approval of the first siRNA drug, ...

Cayman's LipidLaunch™ research-ready LNPs, reagent kits, and screening sets help researchers pursue lipid nanoparticles (LNPs) for the delivery of nucleic acid therapies. LipidLaunch™ Research Tools ...

In a new study led by John T. Wilson, Associate Professor of Chemical and Biomolecular Engineering and Biomedical Engineering, Vanderbilt researchers have created a set of nanoparticles that encourage ...

Ottawa, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The global lipid nanoparticle manufacturing market size is calculated at USD 565 million in 2026 and is expected to reach around USD 2243 million by 2034, ...

Researchers have developed a novel vaccine platform using spherical nucleic acid immunization, which outperforms the best commercially available vaccines when tested on COVID-19-infected mice. A ...

This improved technological platform can be used to develop new treatments, molecular diagnosis strategies or vaccines for various diseases. Research has shown that some nucleic acids, such as ...